Clinical Trial Update: Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paricalcitol for advanced prostate cancer with bone metastases was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Prostate Cancer

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Metastatic Cancer, Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-01-10